The Latest Headlines at Stock Observer
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Receives $44.14 Consensus Target Price from Analysts
Shares of Zenas BioPharma, Inc. (NASDAQ:ZBIO – Get Free Report) have been assigned a consensus recommendation of “Hold” from the nine analysts that are currently covering the stock, Marketbeat Ratings reports. Two... More of this article »
Biogen (NASDAQ:BIIB) Upgraded at UBS Group
UBS Group upgraded shares of Biogen (NASDAQ:BIIB – Free Report) from a neutral rating to a buy rating in a report published on Wednesday morning, Marketbeat reports. They currently have $225.00 price objective on the biotechnology... More of this article »
Brokerages Set CenterPoint Energy, Inc. (NYSE:CNP) Target Price at $44.15
CenterPoint Energy, Inc. (NYSE:CNP – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fifteen brokerages that are currently covering the stock, Marketbeat reports. One equities research... More of this article »
Brokerages Set Hasbro, Inc. (NASDAQ:HAS) Target Price at $112.86
Shares of Hasbro, Inc. (NASDAQ:HAS – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen brokerages that are presently covering the firm, MarketBeat reports. Four research analysts... More of this article »
Brokerages Set BNY (NYSE:BK) Target Price at $137.35
Shares of BNY (NYSE:BK – Get Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen analysts that are currently covering the company, Marketbeat.com reports. Five analysts have rated... More of this article »
Ventas, Inc. (NYSE:VTR) Receives $90.47 Average Price Target from Analysts
Shares of Ventas, Inc. (NYSE:VTR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports. Three research... More of this article »
Actuate Therapeutics’ (ACTU) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Actuate Therapeutics (NASDAQ:ACTU – Free Report) in a report issued on Wednesday morning,Benzinga reports. They currently have a $15.00 target price on the stock. Several... More of this article »
Pinewood Technologies Group’s (PINE) Buy Rating Reiterated at Berenberg Bank
Berenberg Bank restated their buy rating on shares of Pinewood Technologies Group (LON:PINE – Free Report) in a report released on Wednesday morning, Marketbeat Ratings reports. Berenberg Bank currently has a GBX 670 target... More of this article »
hVIVO’s (HVO) “Buy” Rating Reiterated at Shore Capital Group
Shore Capital Group restated their buy rating on shares of hVIVO (LON:HVO – Free Report) in a research note released on Wednesday morning, Marketbeat Ratings reports. Separately, Stifel Nicolaus reiterated a “hold”... More of this article »
GB Group’s (GBG) “Buy” Rating Reiterated at Canaccord Genuity Group
Canaccord Genuity Group restated their buy rating on shares of GB Group (LON:GBG – Free Report) in a research note released on Wednesday,Digital Look reports. They currently have a GBX 400 price target on the stock. Separately,... More of this article »
Bunzl’s (BNZL) “Hold” Rating Reiterated at Stifel Nicolaus
Stifel Nicolaus reissued their hold rating on shares of Bunzl (LON:BNZL – Free Report) in a research report report published on Wednesday,Digital Look reports. Stifel Nicolaus currently has a GBX 2,350 price target on the stock. BNZL... More of this article »
TD Cuts CAE (TSE:CAE) Price Target to C$49.00
CAE (TSE:CAE – Free Report) (NYSE:CAE) had its price objective trimmed by TD from C$53.00 to C$49.00 in a report issued on Wednesday morning,BayStreet.CA reports. The firm currently has a buy rating on the stock. Several other... More of this article »
IAMGOLD (TSE:IMG) Price Target Raised to C$32.00
IAMGOLD (TSE:IMG – Free Report) (NYSE:IAG) had its target price increased by BMO Capital Markets from C$27.00 to C$32.00 in a report published on Wednesday morning,BayStreet.CA reports. Other analysts have also issued reports... More of this article »